Covid 19 Pill Race Intensifies – Human Trials Begin For Breakthrough Treatment

Covid 19 Pill Race Intensifies – Human Trials Begin For Breakthrough Treatment
SHARE

There are various covid 19 treatments that are in the works these days, and the vaccines are also a topic that experts are still discussing.

All these are believed to be able to finally put an end to the pandemic in the middle of which we are for more than a year now.

It’s been just reported that there’s a Japanese company that has already started human trials of the very first pill for Covid 19 patients. This firm has joined Pfizer Inc. and Merck & Co. in the race to find treatments for the disease.

Testing a breakthrough drug 

Osaka-based Shionogi & Co. has been helping develop the blockbuster cholesterol drug Crestor, and it said it designed its pill to attack the Covid-19 virus.

“It said the once-a-day dosing would be more convenient. The company said it is testing the drug and any side effects in trials that began this month and are likely to continue until next year,” News Fr 24 notes. 

It’s also worth noting the fact that Shionogi is months behind Pfizer and Merck, which have started later-stage tests of pills to treat Covid-19.

Source: Pixabay
Source: Pixabay

It’s also relevant to mention the fact that Pfizer has said its twice-daily pill could be ready to hit the market by the end of this year.

Check out the complete original article in order to learn all the available details. 

The latest news on covid Delta variant 

The Delta Covid variant is ruling all the other strains across the globe these days. It’s been already revealed that the Delta variant is the most dangerous one so far, according to more expert opinions across the globe. 

Some experts have already called it “coronavirus on steroids.”

Times Of Israel reports that there’s new data from the UK and Israel that brings more confusion and contradiction about the issue regarding the effectiveness of Pfizer’s covid 19 vaccines. Check out all the details in our previous article. 


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.